Tube formation assay was performed as previously reported46 (link). Briefly, a total of 35 × 104 HUVECs were seeded in Matrigel-coated (Corning, USA) 96-well plates in DMEM-F12 including 1% EV-free FBS. The cells were treated with either 0.5 µg EVs derived from control or ticagrelor treated H9c2 cells. The tube formation was visualized at 6 h and 24 h of incubation by an inverted light microscope (Zeiss, Germany). Branche, mesh, segment, and node formations were analyzed by Angiogenesis Analyzer plug-in for ImageJ (NIH, USA)47 (link). Changes in angiogenesis on EV-treated cells were expressed as a percentage of the controls (untreated cells). Values represent the mean (± SD) of triplicate formation assay.
Free full text: Click here